These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25228578)

  • 21. Bleeding complications during anticoagulant treatment in patients with cancer.
    Kamphuisen PW; Beyer-Westendorf J
    Thromb Res; 2014 May; 133 Suppl 2():S49-55. PubMed ID: 24862146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastrointestinal bleeding, NSAIDs, aspirin and anticoagulants].
    Lanas Á
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():62-70. PubMed ID: 25294267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsule commentary on Leiss et al., Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
    Sevestre MA
    J Gen Intern Med; 2015 Jan; 30(1):92. PubMed ID: 25200060
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleeding.
    Winkelmayer WC
    Ann Intern Med; 2014 Sep; 161(6):JC10. PubMed ID: 25222410
    [No Abstract]   [Full Text] [Related]  

  • 26. The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy.
    Elmi G; Pizzini AM; Silingardi M
    Vascular; 2018 Dec; 26(6):670-682. PubMed ID: 29966487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
    Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
    Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients.
    Montes R; Nantes O; Alonso A; Zozaya JM; Hermida J
    Br J Haematol; 2008 Dec; 143(5):727-33. PubMed ID: 18950464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin for long term maintenance therapy of venous thromboembolism.
    Schellong S
    Vasa; 2013 Mar; 42(2):83-5. PubMed ID: 23485833
    [No Abstract]   [Full Text] [Related]  

  • 30. [Assessment of bleeding risk in patients with venous thromboembolism: we are still a long way from home].
    Klok FA; Huisman MV
    Ned Tijdschr Geneeskd; 2016; 160():D140. PubMed ID: 27378261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACP Journal Club. Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists.
    Lazo-Langner A
    Ann Intern Med; 2015 Oct; 163(8):JC2. PubMed ID: 26502139
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of upper gastrointestinal bleeding from different drug combinations.
    Masclee GM; Valkhoff VE; Coloma PM; de Ridder M; Romio S; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Kuipers EJ; van der Lei J; Sturkenboom MC
    Gastroenterology; 2014 Oct; 147(4):784-792.e9; quiz e13-4. PubMed ID: 24937265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly diagnosed venous thromboembolism: which patients will bleed after anticoagulation is initiated?
    Goldhaber SZ
    Thromb Haemost; 2008 Jul; 100(1):5-6. PubMed ID: 18612527
    [No Abstract]   [Full Text] [Related]  

  • 35. Aspirin bleeding in perspective.
    Morgan G; Elwood P
    Qual Prim Care; 2011; 19(4):251-3. PubMed ID: 21902904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
    Graham DY
    Aliment Pharmacol Ther; 2007 Feb; 25(3):345-6; author reply 346-7. PubMed ID: 17217449
    [No Abstract]   [Full Text] [Related]  

  • 37. How can I predict bleeding in my elderly patient taking anticoagulants?
    Quinn GR; Fang MC
    Cleve Clin J Med; 2016 May; 83(5):345-8. PubMed ID: 27168509
    [No Abstract]   [Full Text] [Related]  

  • 38. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
    Laine L
    Aliment Pharmacol Ther; 2006 Sep; 24(6):897-908. PubMed ID: 16948802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Valkhoff VE; Sturkenboom MC; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coxibs + oral anticoagulants: risk of interaction.
    Prescrire Int; 2002 Jun; 11(59):85-6. PubMed ID: 12068844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.